logo
logo

FundaMental Pharma raised €12.7 million in seed funding, appoints Dr. Dirk Beher as Chief Executive Officer

Apr 11, 2024over 1 year ago

Amount Raised

€12.7 Million

Round Type

seed

HeidelbergTherapeuticsBiotechnologyHealth Care

Investors

Novartis Venture Fund

Description

FundaMental Pharma has appointed Dr. Dirk Beher as Chief Executive Officer and Executive Board member, taking over from co-founder Dr. Thomas Schulze. The company recently raised additional seed funding from new investor, the Novartis Venture Fund, bringing its total seed financing to €12.7 million.

Company Information

Company

FundaMental Pharma

Location

Heidelberg, Baden-Württemberg, Germany

About

FundaMental Pharma GmbH is a neuroscience company spun out of Heidelberg University, dedicated to developing first-in-class small molecule inhibitors for the treatment of a range of neurodegenerative diseases.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People